+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetic Shoes Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805802
The global diabetic shoes market value was USD 7.8 billion in 2022, driven by the increasing prevalence of diabetes and the increasing awareness about the importance of foot care in diabetes management across the globe. The market size is anticipated to grow at a CAGR of 8.2% during the forecast period of 2023-2031 to achieve a value of USD 16.1 billion by 2031.

Diabetic Shoes: Introduction

Diabetic shoes, also known as therapeutic footwear, are specially designed shoes that provide comfort, protection, and support for individuals with diabetes. These shoes are specifically created to address the unique foot care needs of people with diabetes, as they are prone to foot-related complications such as neuropathy, poor circulation, and foot ulcers.

The primary objective of diabetic shoes is to prevent foot injuries, alleviate pressure points, and enhance overall foot health. They feature several key design elements, including extra depth, wide toe boxes, cushioned insoles, and seamless interiors to minimize friction and reduce the risk of developing foot problems.

Key Trends in the Diabetic Shoes Market

Some key trends involved in the diabetic shoes market are as follows:
  • Technological Advancements: One of the significant trends in the diabetic shoes market is the integration of advanced technologies. Manufacturers are incorporating features like pressure sensors, temperature monitoring, and wireless connectivity into diabetic shoes. These technologies help individuals monitor foot health, detect abnormalities, and transmit data to healthcare providers for timely intervention
  • Customization and Personalization: With growing awareness about the importance of proper foot care in diabetes management, there is an increasing demand for customized and personalized diabetic shoes. Companies are offering options for customized shoe sizing, individualized fit adjustments, and even 3D-printed shoes tailored to each person's unique foot shape and needs
  • Fashion and Style: Traditionally, diabetic shoes were associated with functional designs rather than fashion-forward aesthetics. However, there is a growing trend towards incorporating fashionable elements into diabetic shoe designs. Manufacturers are focusing on creating shoes that blend style and functionality, allowing individuals with diabetes to choose from a variety of attractive designs that match their personal preferences
  • Online Retail and Direct-to-Consumer Models: The rise of e-commerce has influenced the distribution channels for diabetic shoes. Online platforms and direct-to-consumer models have gained popularity, enabling individuals to purchase diabetic shoes conveniently from the comfort of their homes. This trend has increased accessibility and expanded the reach of diabetic shoe brands to a wider consumer base

Diabetic Shoes Market Segmentations

Market Breakup by Type

  • Dress Shoes
  • Running Shoes
  • Strolling Shoes
  • Others

Market Breakup by Patient Type

  • Outpatient
  • Inpatient

Market Breakup by Distribution Channel

  • Offline
  • Specialty Stores
  • Hypermarkets and Supermarkets
  • Online

Market Breakup by End User

  • Women
  • Men
  • Children

Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Diabetic Shoes Market Scenario

The market for diabetic shoes has been growing steadily due to the rising prevalence of diabetes and the increasing awareness about the importance of foot care in diabetes management. Diabetic shoes play a crucial role in preventing foot complications and promoting overall foot health among individuals with diabetes.

Diabetic shoes are designed to provide comfort, support, and protection to diabetic patients, who are more susceptible to foot problems. These shoes are equipped with features such as extra depth, wide toe boxes, cushioned insoles, and breathable materials to minimize pressure points, reduce friction, and enhance circulation. They are also often recommended by healthcare professionals as part of a comprehensive foot care plan.

The market for diabetic shoes is driven by several factors. Firstly, the growing diabetic population worldwide is fuelling the demand for diabetic shoes. According to the International Diabetes Federation, the number of people living with diabetes is expected to increase significantly in the coming years. This surge in diabetic cases is creating a greater need for specialized footwear to address the unique foot care needs of these individuals.

In conclusion, the market for diabetic shoes is expanding due to the growing diabetic population, increasing awareness about foot care, and the shift towards online retail. As more individuals recognize the importance of foot health in diabetes management, the demand for diabetic shoes is expected to continue growing. Manufacturers and healthcare providers have the opportunity to capitalize on this market by developing innovative, comfortable, and stylish diabetic shoe options that cater to the specific needs and preferences of individuals with diabetes.

Diabetic Shoes Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Aetrex Worldwide Inc
  • Apis Footwear Company
  • Medical Expo
  • Dr Comfort
  • DARCO Medical India
  • DrewShoe Incorporated
  • Anodyne LLC
  • Podartis Srl
  • Orthofeet Inc
  • Propet USA, Inc.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetes Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetes Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Diabetes Epidemiology (2016-2031)
5.3 Europe Diabetes Epidemiology (2016-2031)
5.4 Asia Pacific Diabetes Epidemiology (2016-2031)
5.5 Latin America Diabetes Epidemiology (2016-2031)
5.6 Middle East and Africa Diabetes Epidemiology (2016-2031)
6 Global Diabetic Shoes Market Overview
6.1 Global Diabetic Shoes Market Historical Value (2016-2022)
6.2 Global Diabetic Shoes Market Forecast Value (2023-2031)
7 Global Diabetic Shoes Market Landscape
7.1 Diabetic Shoes: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Diabetic Shoes: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Patient Type
7.2.3 Analysis by Distribution Channel
7.2.4 Analysis by End User
8 Diabetic Shoes Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Diabetic Shoes Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Diabetic Shoes Market Segmentation
11.1 Global Diabetic Shoes Market by Type
11.1.1 Market Overview
11.1.2 Dress Shoes
11.1.3 Running Shoes
11.1.4 Strolling Shoes
11.1.5 Others
11.2 Global Diabetic Shoes Market by Patient Type
11.2.1 Market Overview
11.2.2 Outpatient
11.2.3 Inpatient
11.3 Global Diabetic Shoes Market by Distribution Channel
11.3.1 Market Overview
11.3.2 Offline
11.3.2.1 Specialty Stores
11.3.2.2 Hypermarkets and Supermarkets
11.3.3 Online
11.4 Global Diabetic Shoes Market by End User
11.4.1 Market Overview
11.4.2 Women
11.4.3 Men
11.4.4 Children
11.5 Global Diabetic Shoes Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Diabetic Shoes Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Diabetic Shoes Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Diabetic Shoes Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Diabetic Shoes Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Diabetic Shoes Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Aetrex Worldwide Inc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Apis Footwear Company
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Medical Expo
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Dr Comfort
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 DARCO Medical India
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 DrewShoe Incorporated
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Anodyne LLC
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Podartis Srl
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Orthofeet Inc.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Propet USA, Inc.
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Diabetic Shoes - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket

Companies Mentioned

  • Aetrex Worldwide Inc.
  • Apis Footwear Company
  • Medical Expo
  • Dr Comfort
  • DARCO Medical India
  • DrewShoe Incorporated
  • Anodyne LLC
  • Podartis Srl
  • Orthofeet Inc.
  • Propet USA Inc.

Methodology

Loading
LOADING...

Table Information